VCP over expression may facilitate malignancy by promoting NSCLC cell growth, proliferation, migration and anti-apoptosis through abnormal expression of several cancer-related proteins, including p53 and NFκB. This evidence concerns the gene TP53 and non-small cell lung carcinoma.